The future of stem cell therapies is very promising. Clinical attrition is decreasing, manufacturing scale-up strategies are more efficient than ever, and the logistics and supply chain frameworks for this sector are much more effective now than they were a few years ago.
We spoke to approximately 200 representatives from this field, and they were all optimistic about stem cells, and were especially excited about the increase in successful clinical data that they see on the horizon. We were inspired by these conversations with industry, and decided to share them with you in the format of this report – the top 15 most promising cell therapies.
The ranking is based on research conducted with leading biotechs, developing stem cells, cell and gene therapies, as well as with government, universities and research institutions.
The selection criteria included:
- Recent successful clinical data
- Effective capital formation strategies
- Stock history
- Awareness across different markets
- Personal recognition
Want to know who made the cut?
If you are interested in this, you may also be interested in World Stem Cells & Regenerative Medicine Congress 2014, taking place this May in London.